A double blind placebo-controlled study of brexpiprazole for the treatment of borderline personality disorder / Jon E. Grant en The British Journal of Psychiatry, Año 2022 - Vol. 220 - No. 2 (Febrero)

Público ISBD [artículo]  inThe British Journal of Psychiatry > Año 2022 - Vol. 220 - No. 2 (Febrero) . - pp. 58 - 63 Título : A double blind placebo-controlled study of brexpiprazole for the treatment of borderline personality disorder Tipo de documento: texto impreso Autores: Jon E. Grant, Autor ; Stephanie Valle, Autor ; Eve Chesivoir, Autor Fecha de publicación: 2022 Artículo en la página: pp. 58 - 63 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno límite de la personalidad, Brexpiprazol, Tratamiento ambulatorio, Ensayo de drogas farmacéuticas, Farmacoterapia Resumen: Borderline personality disorder is associated with impaired quality of life and has a number of untoward public health associations. There is no established first-line pharmacological treatment for borderline personality disorder, and available options are not suitable for all individuals. Link: ./index.php?lvl=notice_display&id=28518 [artículo] A double blind placebo-controlled study of brexpiprazole for the treatment of borderline personality disorder [texto impreso] / Jon E. Grant, Autor ; Stephanie Valle, Autor ; Eve Chesivoir, Autor . - 2022 . - pp. 58 - 63. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The British Journal of Psychiatry > Año 2022 - Vol. 220 - No. 2 (Febrero) . - pp. 58 - 63 Palabras clave: Trastorno límite de la personalidad, Brexpiprazol, Tratamiento ambulatorio, Ensayo de drogas farmacéuticas, Farmacoterapia Resumen: Borderline personality disorder is associated with impaired quality of life and has a number of untoward public health associations. There is no established first-line pharmacological treatment for borderline personality disorder, and available options are not suitable for all individuals. Link: ./index.php?lvl=notice_display&id=28518

Double-blind placebo-controlled study of memantine in trichotillomania and skin-picking disorder / Jon E. Grant en The American Journal of Psychiatry, Año 2023 - Vol. 180 - No. 5 (Mayo)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 5 (Mayo) . - pp. 348-356 Título : Double-blind placebo-controlled study of memantine in trichotillomania and skin-picking disorder Tipo de documento: texto impreso Autores: Jon E. Grant, Autor ; Eve Chesivoir, Autor ; Stephanie Valle, Autor Fecha de publicación: 2023 Artículo en la página: pp. 348-356 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno obsesivo-compulsivo (TOC), Farmacoterapia, Psicofarmacología Resumen: Trichotillomania and skin-picking disorder are underrecognized and often disabling conditions in which individuals repeatedly pull at their hair or pick at their skin, leading to noticeable hair loss or tissue damage. To date there is a severe paucity of evidence-based treatments for these conditions. In this study, the authors sought to determine whether memantine, a glutamate modulator, is more effective than placebo in reducing hair-pulling and skin-picking behavior. Link: ./index.php?lvl=notice_display&id=29985 [artículo] Double-blind placebo-controlled study of memantine in trichotillomania and skin-picking disorder [texto impreso] / Jon E. Grant, Autor ; Eve Chesivoir, Autor ; Stephanie Valle, Autor . - 2023 . - pp. 348-356. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 5 (Mayo) . - pp. 348-356 Palabras clave: Trastorno obsesivo-compulsivo (TOC), Farmacoterapia, Psicofarmacología Resumen: Trichotillomania and skin-picking disorder are underrecognized and often disabling conditions in which individuals repeatedly pull at their hair or pick at their skin, leading to noticeable hair loss or tissue damage. To date there is a severe paucity of evidence-based treatments for these conditions. In this study, the authors sought to determine whether memantine, a glutamate modulator, is more effective than placebo in reducing hair-pulling and skin-picking behavior. Link: ./index.php?lvl=notice_display&id=29985

---

1 (1 - 2 / 2)